Показано 0 из 0
Дата |
---|
20:07 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
2.08
|
2.12
|
2.15
|
2.08
|
2.22
|
2.11
|
|
|
43 231.91
|
182.00
|
2.12
|
2.30
|
2.21
|
2.13
|
2.32
|
2.16
|
|
|
172 548.05
|
287.00
|
2.11
|
2.35
|
2.13
|
2.1018
|
2.33
|
2.20
|
|
|
80 304.99
|
286.00
|
2.12
|
2.30
|
2.05
|
2.02
|
2.33
|
2.19
|
|
|
189 645.86
|
369.00
|
1.99
|
2.10
|
2.04
|
1.98
|
2.08
|
2.07
|
|
|
57 749.13
|
218.00
|
1.96
|
2.11
|
2.03
|
1.96
|
2.13
|
2.02
|
|
|
174 260.89
|
325.00
|
1.95
|
2.30
|
2.07
|
1.9657
|
2.07
|
2.03
|
|
|
33 196.93
|
221.00
|
2.00
|
2.11
|
1.96
|
1.94
|
2.05
|
2.04
|
|
|
59 200.86
|
323.00
|
1.90
|
2.11
|
1.99
|
1.90
|
2.01
|
1.98
|
|
|
102 963.34
|
313.00
|
1.90
|
2.31
|
2.08
|
1.95
|
2.17
|
2.01
|
|
|
194 946.50
|
423.00
|
Acurx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a new class of antibiotics for infections caused by bacteria. Acurx Pharmaceuticals serves customers worldwide.